UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
____________
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (date of earliest event reported): September 15, 2014
Altair Nanotechnologies Inc.
(Exact Name of Registrant as Specified in its Charter)
|
Delaware |
|
1-12497 |
|
33-1084375 |
|
(State or other jurisdiction of |
|
(Commission |
|
(IRS Employer |
|
incorporation or organization) |
|
File Number) |
|
Identification No.) |
|
3019 Enterprise Drive |
46013 | |||
| (Address of Principal Executive Offices) | (Zip Code) | |||
Registrant's Telephone Number, Including Area Code:
(775) 856-2500
N/A
(Former name, former address, and formal fiscal year, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
[ ] Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
[ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
[ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)
[ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)
Item 3.01(d) Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
On September 15, 2014, Altair Nanotechnologies, Inc. (ALTI) (the “Company”) notified the Nasdaq Stock Market that the Company is withdrawing the listing of its common stock, $.001 par value, from the Nasdaq Stock Market.
Item 7.01 Regulation FD Disclosure
On September 15, 2014, the Company issued a press release entitled “Altair Nanotechnologies Notifies the Nasdaq of Voluntary Delisting” providing certain information regarding the Company’s withdrawal from the Nasdaq Stock Market. The full text of the Company’s press release is furnished herewith as Exhibit 99.1.
The information in Item 7.01 and 9.01 of this Current Report on Form 8-K (including the exhibit) is furnished pursuant to General Instruction B.2. of Form 8-K and shall not be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing made by the Company the Securities Act or the Exchange Act, except as expressly set forth by specific reference in such a filing.
ITEM 9.01—FINANCIAL STATEMENTS AND EXHIBITS
The following is filed as an exhibit to this report:
|
Exhibit Number |
Title of Document |
Location | ||
|
99.1 |
Press release dated September 15, 2014 |
Attached |
SIGNATURES
Pursuant to the requirements of the Securities Exchange of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
|
|
Altair Nanotechnologies Inc. |
|
|
|
|
|
|
|
Dated: September 15, 2014 |
|
By /s/ Karen Werner |
|
|
|
|
Karen Werner, Interim Chief Financial Officer |
|
|
|
|
|
|